Medicine for Policymakersis a Journal column that provides decision makers with brief explanations of the meaning and implications for biosecurity of clinical issues. The articles describe, for a nonmedical audience, hospital practices, medical challenges, healthcare delivery issues, and other topics of current interest. Readers may submit ideas to the column's editor, Amesh A. Adalja, MD, through the Journal's editorial office atjfox@upmc-biosecurity.org.
StrausbaughLJ, JerniganDB, LiedtkeLA. National shortages of antimicrobial agents: results of 2 surveys from the Infectious Diseases Society of America Emerging Infections Network. Clin Infect Dis, 2001; 33,9:1495–1501.
6.
BeekmanS, GrahamD, GundlapalliA, PolgreenP. Antimicrobial Agent Shortages and Adverse Patient Outcomes: Results of a 2011 Survey of Infectious Diseases Physicians, 2011. http://idsa.confex.com/idsa/2011/webprogram/Paper32011.html. 2012 April 17.
7.
BelongiaEA, KiekeB, LynfieldR, DavisJP, BesserRE. Demand for prophylaxis after bioterrorism-related anthrax cases, 2001. Emerg Infect Dis, 2005; 11,1:42–47.
